KAYNAKLAR

 

Akut Romatizmal Ateş Tedavisi ve Profilaksisi

  1. Driscoll DJ: Rheumatic Fever and Kawasaki disease. In Mayo Clinic Practice of Cardiology, Third Edition, Mosby-Wolfe Medical Communication. 1997; 1642-8

  2. Kaplan, EL: Acute Rheumatic Fever. In The Heart. Ninth edition, McGraw-Hill Companies. 1998; 1753-8

    3.

  3. Nazlı N: Akut Romatizmal Ateş Tedavisi. Kalp ve Damar Hastalıklarının Tıbbi Tedavisi. Ed. İliçin G., Gürsel G., Hacettepe Taş Kitapçılık, 1980; 131-41

  4. ACC/AHA Guidelines for the management of patients with valvular heart disease. J Am Coll Cardiol. 1998; 32:1486-588

    5.

    İnfektif Endokarditte Değerlendirme ve Tedavi

  5. Wilson WR, Karchmer AW, Dajani AS, et al: Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci, and HACEK microorganisms: American Heart Association. JAMA 1995; 274:1706-1713

  6. Nunley DL, Perlman PE, Endocarditis: Changing trends in epidemiology, clinical and microbiologic spectrum. Postgrad Med 1993; 93:235-8

  7. Daniel WG, Mugge A, Martin RP, et al: Improvement in the diagnosis of abscesses associated with endocarditis by transesophageal echocardiography. N Engl J Med 1991;324:795-800

  8. Shapiro SM, Young E, De Guzman S, et al: Transesophageal echocardiography in diagnosis of infective endocarditis. Chest 1994; 105:377-82

  9. Rubenson DS, Tucker CR, Stinson EB, et al: The use of echocardiography in diagnosing culture- negative endocarditis. Circulation 1981;64:641-646.

  10. Petrou M, Wong K, Albertucci M, Brecker SJ, Yacoub MH: Evaluation of unstented aortic homografts for the treatment of prosthetic aortic valve endocarditis. Circulation 1994; 90:II-198-II-204

    11.  Kalp Hastalığı Olan Gebelerin İzlenmesi

  11. Bonow RO, Carabello B, De Leon AC, et al: ACC/AHA Tastk Force Report. ACC/AHA Guidelines for the Management of Patients With Valvular Heart Disease. J Am Coll Cardiol 1998; 32: 1486-8

  12. Misra M, Chambers JB, Jackson G: Murmurs in pregnancy: an audit of echocardiography. Br Med J 1992; 304: 1413-4

  13. Dajani AS, Taubert KA, Wilson W et al: Prevention of bacterial endocarditis : recommendations by the American Heart Association. Circulation 1997; 96: 358-66

  14. Gohlke-Barwolf C, Acar J, Oakley C, et al: Guidelines for prevention of thromboembolic events in valvular heart disease: Study Group of the Working Group on Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 1995; 16: 1320-30

  15. Oakley C: Heart Disease in Pregnancy. BMJ Publishing Group 1997, London, p.248.

  16. Ginsberg JS, Hirsh J: Use of antithrombotic agents during pregnancy. Chest 1995; 108: 305S-311S.

    17.  Aort Darlığı ve Aort Yetersizliği

  17. Braunwald E: Valvular Heart Disease; in Braunwald E (ed). Heart Disease: a Textbook of Cardiovascular Medicine. WB Saunders Company, 1997

  18. Rahimtoola SH: Aortic valve disease; in Alexander RW, Schlant RC, Fuster V (ed.) Hurst's The Heart. Mc Graw-Hill, 1998

  19. ACC/AHA Guidelines for the Management of Patients with Valvular Heart Disease. J Am Coll Cardiol, 1998; 32: 1486-744

    20.

  20. Karpuz H, Özşahin M, Aebischer N, et al: Usefulness of echocardiographic velocity ratio for detection of significant aortic stenosis. Am J Cardiol, 1999; 84:1101-3

  21. Paulus WJ: Chronic aortic regurgitation; in Crawford MH, Dimarco JD (ed). Cardiology. Mosby 2001

    22.  Mitral Darlığı

  22. Titus JL: Anatomy and pathology of the mitral valve.Surgery for acquired mitral valve disease.Ed.Ellis FH.Saunders Company, Philadelphia-London 1967; 49-95

  23. Braunwald E: Heart Disease A Textbook of Cardiovascular Medicine. 5.editionWB Saunders Comp.pp.1007-17

  24. Bonow et al: ACC/AHA Guidelines for the Management of Patients with Valvular Heart Disease. J Am Coll Cardiol 1998;32(5):1515-25

  25. Rahimtoola SH, Sarano ME, Schaff HV, Frye RL: Mitral Valve Disease, Hurst's The Heart. Ninth Edition pp 1789-1819

  26. Feigenbaum H: Echocardiography. Fifth Ed.Lea-Febiger Philadelphia. 1994; 239-51

  27. Weyman AE: Principles and Practice of Echocardiography.2nd Edition.Lea-Febiger, Philadelphia 1994; 403-26

  28. ACC/AHA Guidelines for the Clinical Application of Echocardiography: Executive Summary J Am Coll Cardiol 1997; 29:862-79

  29. Wilkins GT, Weyman AE, Abascal VM, Block PC, Palacios IF: Percutaneous mitral valvotomy: An analysis of echocardiographic variables related to outcome and mechanism of dilatation. Br Heart J 1988;60:299-308

  30. Inoue K, Owaki T, Nakamura T, Kitamura F, Miyamoto N: Clinical application of transvenous mitral commissurotomy by a new balloon catheter. J Thorac Cardiovasc Surg 1984; 87:394-402

  31. Ünal S, Narin A: Percutaneous balloon valvotomy. Renk Pub.Company.1991

  32. Vahanian A, Iung B, Cormier B: Mitral valvuloplasty. Textbook of Interventional Cardiology. Ed. Topol EJ 3rd edition

  33. Raju BS, Turi ZG, Raju PR, et al: Percutaneous balloon versus surgical closed mitral commissurotomy:10 year follow-up of a randomized trial (abstract) JACC 1999; 1167-175

    34.

    Mitral Yetersizliği

  34. Cheitlin MD, Douglas PS, Parmley WW: 26th Bethesda Conference. J Am Coll Cardiol. 1994;24:874-80

  35. Levine HJ, Gaash WH: Vasoactive drugs in chronic regurgitan lesions of the mitral and aortic valves. J. Am Coll Cardiol 1996;28:1083-91

  36. Schon HR, Schroter G, Barthel P: Schoming A. Quinalapril therapy in patients with chronic mitral regurgitation. J Heart Valve Dis 1994;3:303-12

  37. Beppu S, Nimura Y, Sakakibara H: Smoke like echo in the left atrial cavity in mitral valve disease: its featıre and significance. J Am Coll Cardiol 1985;6:744-9

  38. Blackshear JL, Pearce LA, Asinger RW: Mitral regurgitation associated with reduced thromboembolic events in high-risk patients with non-rheumatic atrial fibrillation. J Am Coll Cardiol 1993;72:840-3

  39. Bonow RE, Nikas D, Elefteriades JA: Valve replacement for regurgitant lesions of aortic or mitral valve in advanced left ventricular dysfunction. Cardiol Clin 1995;13:73-83

  40. Horkotte D, Schulte HD, Bircks W: The effects of chordal preservation on late outcome after mitral valve replacement: a randomised study. J Heart Valve Dis 1993;2:150-8

  41. Chua YL, Schaff HV, Orszulak TA, et al: Outcome of mitral valve repair in patients with preoperative atrial fibrillation: should the maze procedure be combined with mitral valvuloplasty? J Thorac Cardiovasc Surg 1994; 107:408-15

  42. Cohn LH, Rizzo RJ, Adams DH et al: The effects of pathophysiology on the surgical treatment of ischemic mitral regurgitation: operative and late risks of repair versus replacement. Eur J Cardiothorac Surg 1995;9:568-74

    43. Mitral Kapak Prolapsusu

  43. Fontana ME, Sparks EA, Boudoulas H: Mitral valve prolapse and the mitral valve prolapse syndrome. Curr Probl cardiol 1991;16:309-75

  44. Boudoulas H, Kohbash BH, Wooley CF: Mitral valve prolapse: a heterogenous disorder. Prim Cardiol 1991; 17:29-43

  45. Nishimura RA, McGoon MD, Shub C, et al: Echocardiographically documented mitral-valve prolapse: long-term follow-up of 237 patients. N Eng J med 1985; 313:1305-9

  46. O'Rurke RA, Crawford MH: The systolic click-murmur syndrome: clinical recognition and management. Curr Probl cardiol 1976;1:1-60

  47. Winkle RA, Lopes MG, Goodman DJ, et al: Propranolol for patients with mitral valve prolapse. Am Herat J 1977;93:422-7

    48.

    Triküspid Kapak Hastalıkları

  48. Waller BF, Howard J, Fess S: Pathology of tricuspid valve stenosis and pure tricuspid: part III. Clin Cardiol 1995; 18: 225-30

  49. Waller BF, Eble JN, Davey DM, Hawley DA, Pless JE: Etiology of pure tricuspid regurgitation based on annular circumference and leaflet area: analysis of 45 necropsy patients with clinical and morphologic evidence of pure tricuspid regurgitation. J Am Coll Cardiol 1986; 7: 1063-74

  50. Emmanouilides GC, Baylen BG: Pulmonary stenosis. In Adams FH Emmanuilides GC (eds): Heart Disease in Infants, Children, and Adolescent, ed 3 Baltimore, Williams&Wilkins, 1983; 234.

  51. Perloff JK: Postpediatric congenital heart disease: Natural survival patterns. In Roberts WC (ed): Conenial Heart Disease in Adults. Philadelphia, FA, Davis, 1979; 27-51

  52. Nuget EW, Freedom RM, Nora JJ, et al: Clinical course in pulmonary stenosis. Circulation 56 (suppl I): I-38-47, 1997

  53. Lorel DH, Grosmann W: Dynamic and isometric exercise during cardiac catheterisation. In: Baim DS, Grosmann W, eds. Cardiac catheterisation, Angiography, and Intervention. 5th ed. Baltimore, MD: Williams&Wilkins 1996; 281-96

  54. Skudicky D, Essop MR, Sareli P: Efficacy of mitral balloon valvotomy in reducing the severit of associated tricuspid valve regurgitation. Am J Cardiol 1994; 73: 209-11

  55. Goldman L, Caldera DL, Nussbaum SR, et al: Multifactorial index of cardiac risk in noncardac surgical procedures. N Engl J Med 1977; 297: 845-50

  56. Reyes VP, Raju BS, Wynne J, et al: Percutaneous balloon valvuloplas compared with open surgical commissurotomy for mitral stenosis. N Eng J Med 1994; 331: 961-7

  57. Dajani AS, Bisno AL, Chung, et al: Prevention of bacterial endocarditis: recommendations by the American Heart Association. JAMA. 1990: 264: 2919-22

  58. Stein PD, Alpert JS, Copeland J, et al: Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves. Chest. 1992;102(suppl): 445S-455S.

    59. Yapay Kalp Kapaklı Hastaların İzlenmesi

  59. McAnulty JH, Rahimcoole SH: Antitrombotic therapy in valvular heart disease. In: Schlanı R, Alexander RW, eds. Hurst's The Heart, Arieries and Veins. 9th ed New York, NY: McGraw-Hill Publishing Co; 1998;1867-74.

  60. Çobanoğlu A, Fossler CL, Güvendik L, Grunkemeier G, Starr A: Aortic valve replacement with the Starr-Edwards prosthesis: a comparison of the first and second decades of follow-up. Ann Thorac Surg 1988;45:248-52

  61. Cannegieter SC, Rosendaal FR, Briel E: Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. Circulation 1994;89: 635-41

  62. Hcras M, Chesebro JH, Fuster V, el al: High risk of thromboemboli early after bioprosthetic cardiac valve replacement. J Am Coll Cardiol 1995;25:1111-9

  63. Stein PD, Alpen JS, Dalen JE, Horstkotte D, Turpie AGG: Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves. Chest In press.

  64. Al-Khadra AS, Salem DN, Rand WM. Udelson JE, Smith JJ, Konstam MA: Warfarin anticoagulation and survial: a cohort analysis from the Studies of Left Ventricular Dysfunction. J Am Coll Cardiol 1998;31:749-53

  65. Hylok EM, Skates SJ, Sheehan MA, Singer DE: An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with non-rheumatic atrial fibrillation. N Engl J Med 1996;335:540-6

  66. Albertal J, Surton M, Pereyra D, et al: Experience with moderate intensity anticoagulation and aspirin after mechanical valve replacement. A retrospective, non-randomized study. J Heart Valve Dis 1993;2:302-7

  67. Genewein U, Haeberli A, Straub PW, Beer JH: Rebound after cessation of oral anticoagulant therapy: the biochemical evidence. Br J Haematol 1996;92:479-85

  68. Ecman MU, Beshansky JR, Durand-Zaleski I, Levine HJ, Pauker SG: Anticoagulation for noncardiac procedures in patients with prosthetic heart valves:does low risk mean high cost? JAMA 1990;263:1513-21

  69. Moreno-Cabral RJ, Mc Namara JJ, Maniya RT, Brainard SC, Chung GK: Acute thrombotic obstraction with Bjork-Shiley valves:diagnostic and surgical considerations. J Thorac Cardiovasc Surg 1978;75:321-30

  70. Lengyel M, FusterV, Keltai M, et al: Guidelines for management of left-sided prosthetic valve thrombosis:a rote for thrombolytic therapy: Consensus Conference on Prosthetic Valve Thrombosis. J Am Coll Cardiol 1997; 30:1521-6

  71. Rahimtoola SH: Valve prosthesis-patient mismatch: an update. J Heart Valve Dis 1998;7:207-10

  72. Rahimtoola SH: Early valve replacement for preservation of ventricular function? Am J Cardiol 1977; 40:472-5

  73. Cosgrove DM, Lyle BW, Taylor PC, et al: The Carpentier-Edwards pericardial aortic valve, ten-year results. J Thorac Cardiovasc Surg 1995;110:651-62

  74. Gueret P, Vignon P, Fournier P, et al: Transesophageal Echocardiography for the Diagnosis and management of nonobstructive Thrombosis of Mechanical Mitral valve prosthesis Circulation 1995; 91:103-10

    75.

  75. Özkan M, Kaymaz C, Kırma C, et al: Intravenous Thrombolytic Treatment of Mechanical Prosthetic Valve Thrombosis: A Study using serial transesophageal Echocardiography J Am Coll Cardiol 2000: 35:1881-9